Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial

Aaron I. Vinik, Vera Bril, Peter Kempler, William J. Litchy, Solomon Tesfaye, Karen L. Price, Edward J. Bastyr

Research output: Contribution to journal › Article › peer-review

124 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences